Celula Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Celula General Information

Description

Provider of diagnostic testing services focused on enhancing the accuracy of disease diagnosis. The company specializes in improving the diagnostic accuracy of major women's diseases, specifically in gynecologic cancers and non-invasive prenatal diagnosis, helping healthcare professionals by offering cost-effective diagnostic resolutions.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 11011 Torreyana Road
  • Suite 200
  • San Diego, CA 92121
  • United States
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Biotechnology
Parent Company
Corporate Office
  • 11011 Torreyana Road
  • Suite 200
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celula Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 01-Jan-2016 Completed Generating Revenue
8. Debt - General 31-Mar-2015 Completed Generating Revenue
7. Later Stage VC (Series C) 02-Apr-2014 Completed Generating Revenue
6. Later Stage VC 30-Jun-2011 Completed Generating Revenue
5. Later Stage VC (Series B1) 18-May-2010 Completed Generating Revenue
4. Grant 22-Sep-2008 Completed Generating Revenue
3. Early Stage VC Completed Generating Revenue
2. Early Stage VC (Series A) Completed Generating Revenue
1. University Spin-Out Completed Generating Revenue
To view Celula’s complete valuation and funding history, request access »

Celula Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C2
Series C1
Series C
Series B1
Series B
Series A1 337,777 $0.000100 $1.1 $1.1 1x $1.1 0.47%
Series A 139,997 $0.000100 $1.1 $1.1 1x $1.1 0.2%
To view Celula’s complete cap table history, request access »

Celula Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of diagnostic testing services focused on enhancing the accuracy of disease diagnosis. The company specializes
Laboratory Services (Healthcare)
San Diego, CA
11 As of 2016

Hayward, CA
 

Dublin, Ireland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Celula Competitors (11)

One of Celula’s 11 competitors is DiaCarta, a Venture Capital-Backed company based in Hayward, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DiaCarta Venture Capital-Backed Hayward, CA
Genuity Science Formerly VC-backed Dublin, Ireland
DalCor Pharmaceuticals Venture Capital-Backed Montreal, Canada
BPS Bioscience Corporation San Diego, CA
Personalis Formerly VC-backed Fremont, CA
You’re viewing 5 of 11 competitors. Get the full list »

Celula Patents

Celula Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2864472-A1 Materials and methods for processing cell populations Inactive 20-Jun-2012
EP-2864472-A4 Materials and methods for processing cell populations Inactive 20-Jun-2012
WO-2013192342-A1 Materials and methods for processing cell populations Inactive 20-Jun-2012
WO-2013010134-A2 Systems, apparatus and methods for biochemical analysis Inactive 14-Jul-2011
WO-2013010134-A3 Systems, apparatus and methods for biochemical analysis Inactive 14-Jul-2011 B01L3/5027
To view Celula’s complete patent history, request access »

Celula Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Celula Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARCH Venture Partners Venture Capital Minority
CHL Medical Partners Venture Capital Minority
Enterprise Partners Venture Capital Venture Capital Minority
Kaiser Permanente Ventures Corporate Venture Capital Minority
Skyline Ventures Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Celula FAQs

  • When was Celula founded?

    Celula was founded in 2005.

  • Where is Celula headquartered?

    Celula is headquartered in San Diego, CA.

  • What is the size of Celula?

    Celula has 11 total employees.

  • What industry is Celula in?

    Celula’s primary industry is Laboratory Services (Healthcare).

  • Is Celula a private or public company?

    Celula is a Private company.

  • What is Celula’s current revenue?

    The current revenue for Celula is .

  • How much funding has Celula raised over time?

    Celula has raised $50.2M.

  • Who are Celula’s investors?

    ARCH Venture Partners, CHL Medical Partners, Enterprise Partners Venture Capital, Kaiser Permanente Ventures, and Skyline Ventures are 5 of 7 investors who have invested in Celula.

  • Who are Celula’s competitors?

    DiaCarta, Genuity Science, DalCor Pharmaceuticals, BPS Bioscience, and Personalis are some of the 11 competitors of Celula.

  • When was Celula acquired?

    Celula was acquired on 01-Jan-2016.

  • Who acquired Celula?

    Celula was acquired by NeoSeq.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process